Martin Shkreli Quotes
If you have a drug that is $100 for one course of therapy, and you know that you can charge $100,000, what should shareholders think when you say, 'I'd rather not take the heat'?
Topics
Business Ethics
Corporate Responsibility
Healthcare Costs, Medical Care Costs
Price Gouging
Profit Motive
Cost of Treatment
Drug Pricing
Ethical Business Practices
Financial Ethics
Market Competition
Pharmaceutical Pricing
Profit Margins
Regulatory Compliance
Shareholder Value
Profit Priority
Citations
Herper, Matthew. "Martin Shkreli At The Forbes Healthcare Summit." Forbes, Forbes Media, 3 Dec. 2015.
Related Quotes
Martin Shkreli, called "Pharma Bro" by some media, is an American former hedge fund manager and convicted felon. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare; the co-founder and former chief executive officer (CEO) of the pharmaceutical firms Retrophin and Turing Pharmaceuticals (now Vyera Pharmaceuticals); and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.
Related Authors